Additionally, the Nrf2 pathway activity affects the inhibition of ROS and the reduction of Aβ deposits and tau phosphorylation in AD animal models and human cell lines expressing AD pathology [52]. The gene discussed is MAPT; the disease is Alzheimer disease.